Alerts will be sent to your verified email
Verify EmailDIVISLAB
Divi's Lab
|
Aurobindo Pharma
|
Laurus Labs
|
|
---|---|---|---|
Operational Metrics
|
|||
Pharmaceutical Sector
|
|||
R&D as a % of Total Sales
|
0.91 % | 5.41 % | 4.8 % |
Financials
|
|||
5 yr Average ROE
|
19.83 % | 15.24 % | 20.49 % |
5yr average Equity Multiplier
|
1.24 | 1.59 | 2.07 |
5yr Average Asset Turnover Ratio
|
0.57 | 0.72 | 0.76 |
5yr Avg Net Profit Margin
|
27.57 % | 13.0 % | 12.66 % |
Price to Book
|
8.43 | 2.35 | 5.73 |
P/E
|
77.27 | 23.92 | 146.73 |
5yr Avg Cash Conversion Cycle
|
141.33 Days | -29.67 Days | 86.64 Days |
Inventory Days
|
115.55 Days | 60.22 Days | 104.93 Days |
Days Receivable
|
98.41 Days | 30.42 Days | 88.66 Days |
Days Payable
|
95.88 Days | 111.73 Days | 140.44 Days |
5yr Average Interest Coverage Ratio
|
995.2 | 43.11 | 9.21 |
5yr Avg ROCE
|
24.63 % | 18.43 % | 24.83 % |
5yr Avg Operating Profit Margin
|
39.96 % | 20.43 % | 24.94 % |
5 yr average Debt to Equity
|
0.0 | 0.27 | 0.57 |
5yr CAGR Net Profit
|
6.15 % | -4.01 % | 52.94 % |
5yr Average Return on Assets
|
15.99 % | 9.53 % | 9.8 % |
Shareholdings
|
|||
Promoter Holding
|
51.92 % | 51.83 % | 27.19 % |
Share Pledged by Promoters
|
0.0 | 20.86 % | 0.0 |
Change in Promoter Holding (3 Yrs)
|
-0.03 % | -0.11 % | -0.26 % |
Change in Mutual Fund Holding (3 Yrs)
|
1.69 % | 8.99 % | 4.63 % |
Divi's Lab
|
Aurobindo Pharma
|
Laurus Labs
|
|
---|---|---|---|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Brand Wise Break-Up
|
Brand Wise Break-Up
|
-
|
-
|
Asset Break-Up
|
Asset Break-Up
|
Asset Break-Up
|
-
|